UNSW scientists have grown human pancreatic cancer tumors in the lab—their model is the first of its kind, with important future clinical implications.
Jan 22, 2021
0
33
Researchers at Rush University Medical Center have found that opioid use might increase a person's risk of developing pancreatic cancer.
Jan 06, 2021
0
64
A first-of-its-kind randomized clinical trial found that patients with pancreatic cancer didn't live any longer than expected after receiving pre-operative chemotherapy from either of the two standard regimens, according ...
Jan 21, 2021
0
7
A protein found commonly in human blood might help with the detection of hard-to-diagnose pancreatic tumors. Researchers at Martin Luther University Halle-Wittenberg (MLU), the Alfried Krupp Hospital in Essen and the University ...
Jan 21, 2021
0
4
Pancreatic cancer is a malignant neoplasm of the pancreas. Each year in the United States, about 42,470 individuals are diagnosed with this condition and 35,240 die from the disease. The prognosis is generally poor; less than 5 percent of those diagnosed are still alive five years after diagnosis. Complete remission is still extremely rare. About 95% of exocrine pancreatic cancers are adenocarcinomas (M8140/3). The remaining 5% include adenosquamous carcinomas, squamous cell carcinomas, and giant cell carcinomas. Exocrine pancreatic cancers are far more common than endocrine pancreatic cancers (islet cell carcinomas), which make up about 1% of total cases.
This text uses material from Wikipedia, licensed under CC BY-SA
